Yeji
FDA approvalconf 0.99

tryngolza — FDA approval

$IONS · IONIS PHARMACEUTICALS INC
Event date
June 24, 2026
33 days ago
Sponsor runway
7 mo
$1.92B liquid

Evidence

“On June 24, 2026, Ionis Pharmaceuticals, Inc. ("Ionis") issued a press release announcing that the U.S. Food and Drug Administration ("FDA") has approved TRYNGOLZA® (olezarsen) as an adjunct to diet to reduce triglycerides ("TG") and the risk of acute pancreatitis in adults with severe hypertriglyceridemia ("sHTG": TG greater than or equal to 500 mg/dL).”
Source: 8-K filed 2026-06-24View on EDGAR ↗0001140361-26-026232

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

8 insiders · 0 buys · 15 sells
Exercise10b5-1
2026-05-14
Monia Brett P
Chief Executive Officer
3,220 @ $32.60$105K
Sell10b5-1
2026-05-14
Monia Brett P
Chief Executive Officer
3,220 @ $78.68$253K
Exercise10b5-1
2026-05-13
Monia Brett P
Chief Executive Officer
1,316 @ $32.60$43K
Sell10b5-1
2026-05-13
Monia Brett P
Chief Executive Officer
1,316 @ $78.01$103K
Exercise10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
10,968 @ $38.06$417K
Exercise10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
16,000 @ $42.88$686K
Exercise10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
10,321 @ $41.08$424K
Exercise10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
12,000 @ $40.05$481K
Sell10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
17,781 @ $75.58$1.34M
Sell10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
59,508 @ $74.90$4.46M
Sell10b5-1
2026-05-01
KLEIN JOSEPH III
Director
8,680 @ $73.35$637K
Sell10b5-1
2026-05-01
KLEIN JOSEPH III
Director
1,431 @ $74.45$107K
Exercise10b5-1
2026-05-01
KLEIN JOSEPH III
Director
10,111 @ $47.11$476K
Sell10b5-1
2026-04-28
Baroldi Joseph
EVP, Chief Business Officer
1,626 @ $71.79$117K
Sell
2026-04-16
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
4,902 @ $75.17$368K
Sell
2026-04-16
Birchler Brian
EVP, Corp and Development Ops
973 @ $75.04$73K
Sell
2026-04-16
Baroldi Joseph
EVP, Chief Business Officer
5,619 @ $74.56$419K
Exercise
2026-04-15
Birchler Brian
EVP, Corp and Development Ops
1,875 @ ——
Sell10b5-1
2026-04-15
PARSHALL B LYNNE
Director
4,466 @ $76.19$340K
Sell10b5-1
2026-04-15
PARSHALL B LYNNE
Director
534 @ $76.97$41K
Exercise
2026-04-15
Baroldi Joseph
EVP, Chief Business Officer
10,837 @ ——
Exercise
2026-04-15
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
12,226 @ ——
Sell10b5-1
2026-04-02
Devers Shannon L.
EVP, Chief Human Resources Ofc
6,193 @ $74.05$459K
Exercise10b5-1
2026-04-01
KLEIN JOSEPH III
Director
12,000 @ $38.06$457K
Exercise10b5-1
2026-04-01
KLEIN JOSEPH III
Director
10,321 @ $41.08$424K
Sell10b5-1
2026-04-01
KLEIN JOSEPH III
Director
20,105 @ $75.50$1.52M
Sell10b5-1
2026-04-01
KLEIN JOSEPH III
Director
2,216 @ $75.95$168K
← All catalysts for $IONS